Patheon Acquires Agere Pharmaceuticals
Patheon has agreed to acquire Agere Pharmaceuticals, a privately held contract development and manufacturing organization, headquartered in Bend, Oregon. Agere specializes in solubilization technologies and related science to improve the bioavailability of drugs.
Agere’s Bend, Oregon facility is expected to serve as a solubility center of excellence and be part of Patheon's pharmaceutical development services (PDS) operations. In the last year, Patheon has expanded its capabilities through several key acquisitions, including the addition of a large-scale facility in Greenville, North Carolina. Patheon’s PDS solutions offer advanced scientific and preformulation services for characterizing drug substances, developing and implementing laboratory methodologies, and generating data to enable investigational new drug filings.
On the drug substance side, earlier this month, Patheon agreed to acquire IRIX Pharmaceuticals, which focuses on difficult-to-manufacture active pharmaceutical ingredients (APIs) from early and late development through commercial launch. With the acquisition, Patheon secures additional API development and manufacturing services in the US, including high-potency (SafeBridge Class IV certified) and controlled substances (Schedule 1-4) IRIX has commercial API manufacturing at sites in Greenville and Florence, South Carolina.